Figure 2.
Changes in estimated glomerular filtration rate (eGFR) in patients with or without sodium–glucose cotransporter 2 inhibitor (SGLT2i) administration (n = 17 and 58, respectively). The change in eGFR 2 years after initiation in the 2 years after baseline. Data are presented as the mean ± standard deviation (SD). *P < 0.05 between the groups.